Rahul D. Ballal insider trades

Open-market stock purchases and sales by Rahul D. Ballal, Director at Agios Pharmaceuticals, Inc, from SEC Form 4 filings since Dec 14, 2020.

Recent trades

DateStockTradeValue
Jun 18, 2026AGIO Agios Pharmaceuticals, IncBought (not open market)—
Jun 18, 2026AGIO Agios Pharmaceuticals, IncBought (not open market)—
Jun 18, 2026AGIO Agios Pharmaceuticals, IncBought (not open market)—
Feb 12, 2026ELVN Enliven Therapeutics, IncBought (not open market)—

Companies traded

  • AGIO Agios Pharmaceuticals, Inc: 5 sales, last Jun 18, 2026
  • ELVN Enliven Therapeutics, Inc: 8 sales, last Feb 12, 2026
  • IMRA IMARA Inc: 4 sales, last Feb 22, 2023

Get free alerts when Rahul D. Ballal files a new trade →